التفاصيل البيبلوغرافية
| العنوان: |
Improved Glucose Variability by Imeglimin (Twymeeg) After Hypoglycemic Episode in T2D Patient |
| المؤلفون: |
Bando, Hiroshi, Ogawa, H, Kobayashi, H, Nagahiro, Shinji, Nakanishi, S, Watanabe, O |
| بيانات النشر: |
SunText Reviews |
| سنة النشر: |
2024 |
| المجموعة: |
Tokushima University Institutional Repository / 徳島大学機関リポジトリ |
| مصطلحات موضوعية: |
Imeglimin (Twymeeg), Glubes (mitiglinide/voglibose), EquMet (Vildagliptin/Metformin), Trials of IMeglimin for Efficacy and Safety (TIMES), Oral hypoglycemic agent (OHA) |
| الوصف: |
For latest topic, imeglimin (Twymeeg) shows clinical efficacy among several oral hypoglycemic agents (OHAs). The case is 79-year-old male with Type 2 diabetes (T2D) for long. He had hypoglycemic episode in Sept 2022, and then Glubes (mitiglinide/voglibose) was discontinued and EquMet (Vildagliptin/Metformin) was started in Oct 2022. His HbA1c increased to 8.3% in Jan 2023, followed by initiating Twymeeg. Clinical efficacy showed satisfactory degree for glucose variability as 7.3% for 8 weeks. He has body mass index (BMI) 22.0 kg/m2, and daily exercise habit. These factors may contribute diabetic improvement in addition to clinical efficacy of EquMet and Twymeeg. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| تدمد: |
27715469 |
| العلاقة: |
http://repo.lib.tokushima-u.ac.jp/files/public/11/119177/2024040315204835430/srec_2_1_109.pdfTest; http://repo.lib.tokushima-u.ac.jp/119177Test |
| الإتاحة: |
http://repo.lib.tokushima-u.ac.jp/119177Test |
| حقوق: |
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0Test/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| رقم الانضمام: |
edsbas.BF99E69E |
| قاعدة البيانات: |
BASE |
